For the Inventor, By the Inventor

Enter assignee name

Craigavon, United Kingdom

Almac Discovery Limited

USPTO Granted Patents = 12

% Expired Patents = 41.7

CIPO Patents = 2

EPO Patents = 11

Forward Citations = 22

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

Frank Burkamp (9 out of 12 patents)

Colin O'Dowd (7 out of 9 patents)

Timothy Harrison (7 out of 73 patents)

4. James Samuel Shane Rountree (6 out of 6 patents)

5. Peter Hewitt (3 out of 5 patents)

6. Matthew Duncan Helm (3 out of 3 patents)

7. Lixin Zhang (3 out of 3 patents)

8. Graham Peter Trevitt (3 out of 3 patents)

9. Mary Melissa McFarland (2 out of 2 patents)

10. Christina Bell (2 out of 2 patents)

11. Andrew Wilkinson (2 out of 4 patents)

12. Adam Piotr Treder (2 out of 2 patents)

13. Tracy Robson (2 out of 2 patents)

14. Andrea Valentine (2 out of 2 patents)

15. Martin Gerard O'Rourke (2 out of 2 patents)

12 patents: Sort by Forward Citations

1. 12466805 - Pharmaceutical compounds (2025-11-11),

2. 12324837 - ROR1-specific antigen binding molecules (2025-06-10),

3. 11807646 - 4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19) (2023-11-07),

4. 11053213 - Pharmaceutical compounds (2021-07-06),

5. 10766903 - Piperidine derivatives as inhibitors of ubiquitin specific protease 7 (2020-09-08),

6. 10766902 - Wee-1 inhibiting pyrazolopyrimidinone compounds (2020-09-08),

7. 10577406 - FKBP-L polypeptides and uses in angiogenesis-mediated disorders (2020-03-03),

8. 9714244 - Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors (2017-07-25),

9. 9381228 - FKBP-L and uses thereof (2016-07-05),

10. 9221838 - Inhibitors of AKT activity (2015-12-29),

11. 9156853 - AKT inhibitor compounds for treatment of cancer (2015-10-13),

12. 8546376 - Pharmaceutical compounds (2013-10-01),

Almac Discovery Limited is a biopharmaceutical company specializing in the discovery and development of innovative small molecule therapeutics. With a focus on oncology and central nervous system disorders, Almac Discovery is committed to delivering novel drug candidates to address unmet medical needs. The company's expertise in medicinal chemistry, biology, and drug development allows for the rapid advancement of promising compounds through preclinical and clinical studies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

12 Patents

#2 in Craigavon

#1,452 in United Kingdom

#48,036 in the World

Craigavon, United Kingdom

Almac Discovery Limited

Forward Citations = 22

47 inventors:

Frank Burkamp (9 out of 12 patents)

Colin O'Dowd (7 out of 9 patents)

Timothy Harrison (7 out of 73 patents)

4. James Samuel Shane Rountree (6 out of 6 patents)

5. Peter Hewitt (3 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…